Alice Zhou
Overview
Explore the profile of Alice Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Price M, Ruck J, Dilwali N, Thomas A, Zhou A, Gorijavolu R, et al.
Pediatr Transplant
. 2024 Dec;
29(1):e14885.
PMID: 39641150
Introduction: Incidence of and risk factors for early hospital readmission (EHR) are poorly defined in pediatric liver transplant recipients. Therefore, we evaluated EHR incidence and risk factors for pediatric liver...
2.
Wang H, Dun C, Makary M, Walsh C, Fan Y, Rodriguez E, et al.
J Thorac Cardiovasc Surg
. 2024 Oct;
PMID: 39461413
Objective: Mitral valve repair is the preferred treatment for primary mitral regurgitation and offers significant short- and long-term advantages over valve replacement. This study was designed to evaluate the contemporary...
3.
Phillipps J, Nassief G, Morecroft R, Adeyelu T, Elliott A, Abdulla F, et al.
NPJ Precis Oncol
. 2024 Sep;
8(1):187.
PMID: 39232122
Modern advancements in targeted therapy and immunotherapy have significantly improved survival outcomes for advanced melanoma; however, there remains a need for novel approaches to overcome disease progression and treatment resistance....
4.
Morecroft R, Phillipps J, Zhou A, Butt O, Khaddour K, Johanns T, et al.
Front Oncol
. 2024 May;
14:1385094.
PMID: 38779101
Immunotherapy is the first-line option for treating advanced cutaneous squamous cell carcinoma (cSCC). However, up to half of patients experience no benefit and treatment resistance, warranting newer therapeutic approaches. Combinatory...
5.
Eisenson D, Hisadome Y, Santillan M, Iwase H, Chen W, Shimizu A, et al.
Nat Commun
. 2024 Apr;
15(1):3361.
PMID: 38637524
Xenotransplantation represents a possible solution to the organ shortage crisis and is an imminent clinical reality with long-term xenograft survival in pig-to-nonhuman primate (NHP) heart and kidney large animal models,...
6.
Zhou A, Templeton A, Johnson J
Geobiology
. 2024 Feb;
22(1):e12587.
PMID: 38385601
Chemical sedimentary deposits called Banded Iron Formations (BIFs) are one of the best surviving records of ancient marine (bio)geochemistry. Many BIF precursor sediments precipitated from ferruginous, silica-rich waters prior to...
7.
Rhim J, Zhou A, Amenabar M, Boyer G, Elling F, Weber Y, et al.
Appl Environ Microbiol
. 2024 Jan;
90(2):e0136923.
PMID: 38236067
The degree of cyclization, or ring index (RI), in archaeal glycerol dibiphytanyl glycerol tetraether (GDGT) lipids was long thought to reflect homeoviscous adaptation to temperature. However, more recent experiments show...
8.
Wu X, Zhou A, Heller M, Chi T, Kohlbrenner R
Radiology
. 2023 Dec;
309(3):e230555.
PMID: 38085076
Background Benign prostatic hyperplasia (BPH) is a disease that affects millions of U.S. men and is costly to treat. Purpose To compare the cost-effectiveness of four minimally invasive therapies (MITs)...
9.
Khaddour K, Zhou A, Butt O, Huang J, Ansstas G
Front Oncol
. 2023 Oct;
13:1276729.
PMID: 37799464
Oligometastatic progression represents a unique manifestation of tumor immune-escape that can lead to disease progression during treatment with immune checkpoint inhibitor (ICI). The diagnosis and further optimal management of oligometastatic...
10.
Strelnikov J, Zhou A, Butt O, Ansstas M, Ansstas G
J Natl Compr Canc Netw
. 2023 Aug;
21(10):991-999.
PMID: 37647938
Targeted and immune therapies have changed the paradigm of treatment for patients with metastatic melanoma. Treatment of patients with symptomatic melanoma brain metastases, however, is complicated by the frequent use...